Syncopes during simultaneous use of terfenadine and itraconazole;Wegrakingen tijdens simultaan gebruik van terfenadine en itraconazol

Nederlands Tijdschrift voor Geneeskunde

Volumn 141, Issue 19, 1997, Pages 950-953

  Romkes, J H ^a   Froger, C L ^a   Wever, E F D ^a   Westerhof, P W ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ISOPRENALINE; ITRACONAZOLE; TERFENADINE;

ADULT; ARTICLE; CASE REPORT; DRUG WITHDRAWAL; ELECTROCARDIOGRAM; FEMALE; HAY FEVER; HUMAN; LONG QT SYNDROME; MYCOSIS; SYNCOPE; TORSADE DES POINTES;

ADULT; ANTI-ALLERGIC AGENTS; ANTIFUNGAL AGENTS; CARDIOTONIC AGENTS; FEMALE; HUMANS; ISOPROTERENOL; ITRACONAZOLE; LONG QT SYNDROME; MYCOSES; RHINITIS, ALLERGIC, SEASONAL; SYNCOPE; TERFENADINE;

EID: 0030923124     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Jackman WM, Friday KJ, Anderson JL, Aliot EM, Clark M, Lazara R. The long QT syndromes: a critical review, new clinical observations and a unifying hypothesis. Progr Cardiovasc Dis 1988;31:115-72.
2. Symanski JD, Gettes LS. Drug effects on the electrocardiogram. A review of their clinical importance. Drugs 1993;46:219-48.
3. Koh K, Rim M, Yoon J, Kim S. Torsade de pointes induced by terfenadine in a patient with long QT syndrome. J Electrocardiol 1994; 27:343-6.
4. Morganroth J, Brown AM, Critz S, Crumb WJ, Kunze DL, Lacerda AE, et al. Variability of the QTc interval: impact on defining drug effect and low-frequency cardiac event. Am J Cardiol 1993;72:26B-31B.
5. Broadhurst P, Nathan AW. Cardiac arrest in a young woman with the long QT syndrome and concomitant astemizole ingestion. Br Heart J 1993;70:469-70.
6. Yang T, Prakash C, Roden DM, Snyders DJ. Mechanism of block of a human cardiac potassium channel by terfenadine racemate and enantiomers. Br J Pharmacol 1995;115:267-74.
7. Rampe D, Wible B, Brown AM, Dage RC. Effects of terfenadine and its metabolites on a delayed rectifier K+ channel cloned from human heart. Mol Pharmacol 1993;44:1240-5.
8. Bossche H van den, Heeres J, Backx L, Marichal P, Willems G. Discovery, chemistry, mode of action, and selectivity of itraconazole. In: Rippon JW, Fromtling RA, editors. Cutaneous antifungal agents. New York: Dekker, 1993:263-83.
9. Grant SM, Clissold SP. Itraconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in superficial and systemic mycoses. Drugs 1989;37:310-44.
10. Woosley RL, Chen Y, Freiman JP, Gillis RA. Mechanism of the cardiotoxic actions of terfenadine. JAMA 1993;209:1532-6.
11. Pohjola-Sintonen S, Viitasalo M, Toivonen L, Neuvonen P. Torsades de pointes after terfenadine-itraconazole interaction. BMJ 1993;306:186.
12. Zimmermann M, Duruz H, Guinand O, Broccard O, Levy P, Lacatis D, et al. Torsades de pointes after treatment with terfenadine and ketoconazole. Eur Heart J 1992;13:1002-3.
13. Farmacotherapeutisch kompas 1996. In: Kuy A van der, redacteur. Medisch farmaceutische voorlichting. Amstelveen: Centrale Medisch Pharmaceutische Commissie van de Ziekenfondsraad, 1996:958.
14. Tzivoni D, Banai S, Schuger C, Benhorin J, Keren A, Gottlieb S, et al. Treatment of torsade de pointes with magnesium sulfate. Circulation 1988;77:392-7.
15. Klauw MM van der, Rey FJW van, Stricker BHCh. Polymorfe ventriculaire tachycardie met torsades de pointes bij gebruik van terodiline (Mictrol). Ned Tijdschr Geneeskd 1992;136:91-3.